Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray,Mathieu Laversanne,Hyuna Sung,Jacques Ferlay,Rebecca L. Siegel,Isabelle Soerjomataram,Ahmedin Jemal
DOI: https://doi.org/10.3322/caac.21834
2024-04-06
CA A Cancer Journal for Clinicians
Abstract:This article presents global cancer statistics by world region for the year 2022 based on updated estimates from the International Agency for Research on Cancer (IARC). There were close to 20 million new cases of cancer in the year 2022 (including nonmelanoma skin cancers [NMSCs]) alongside 9.7 million deaths from cancer (including NMSC). The estimates suggest that approximately one in five men or women develop cancer in a lifetime, whereas around one in nine men and one in 12 women die from it. Lung cancer was the most frequently diagnosed cancer in 2022, responsible for almost 2.5 million new cases, or one in eight cancers worldwide (12.4% of all cancers globally), followed by cancers of the female breast (11.6%), colorectum (9.6%), prostate (7.3%), and stomach (4.9%). Lung cancer was also the leading cause of cancer death, with an estimated 1.8 million deaths (18.7%), followed by colorectal (9.3%), liver (7.8%), female breast (6.9%), and stomach (6.8%) cancers. Breast cancer and lung cancer were the most frequent cancers in women and men, respectively (both cases and deaths). Incidence rates (including NMSC) varied from four‐fold to five‐fold across world regions, from over 500 in Australia/New Zealand (507.9 per 100,000) to under 100 in Western Africa (97.1 per 100,000) among men, and from over 400 in Australia/New Zealand (410.5 per 100,000) to close to 100 in South‐Central Asia (103.3 per 100,000) among women. The authors examine the geographic variability across 20 world regions for the 10 leading cancer types, discussing recent trends, the underlying determinants, and the prospects for global cancer prevention and control. With demographics‐based predictions indicating that the number of new cases of cancer will reach 35 million by 2050, investments in prevention, including the targeting of key risk factors for cancer (including smoking, overweight and obesity, and infection), could avert millions of future cancer diagnoses and save many lives worldwide, bringing huge economic as well as societal dividends to countries over the forthcoming decades.
oncology
What problem does this paper attempt to address?
This paper focuses on global cancer statistics and analyzes the incidence and mortality rates of different types of cancer worldwide in 2022 based on the latest estimates from the International Agency for Research on Cancer (IARC). The report states that there are approximately 20 million new cancer cases (excluding non-melanoma skin cancer) and nearly 10 million cancer deaths worldwide in 2022. Lung cancer is the most common diagnosed cancer, followed by female breast cancer, colorectal cancer, and prostate cancer. Lung cancer is also the leading cause of cancer-related deaths. The paper also highlights geographical disparities, with Asia accounting for nearly half of the global cancer cases and more than half of the cancer deaths. Africa and Asia have higher cancer mortality rates relative to the incidence rates, which may be attributed to late-stage diagnosis and higher case fatality rates. Although Europe has a smaller population proportion, it has higher cancer incidence and mortality rates. The authors discuss the distribution of the top ten common types of cancer in 20 world regions and predict that by 2050, with the changing population structure, new cancer cases may increase to 35 million. They also explore the relationship between these cancers and risk factors such as smoking, overweight and obesity, and infections, emphasizing the importance of global cancer prevention and control. In addition, the paper provides data on cancer incidence and mortality rates grouped by gender, region, and Human Development Index (HDI), showing the diversity in cancer burden across different regions. For example, prostate cancer is the most common cancer in males, while breast cancer is the most common cancer in females. Lung cancer is the leading cause of death for both males and females worldwide. Overall, this paper aims to depict the current status of global cancer, highlighting the impact of cancer on society, public health, and the economy, and proposing directions for future cancer prevention and control strategies.